The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Response of germline and somatic smoothened (SMO) mutations in non-small cell lung cancer (NSCLC) to hedgehog inhibitor vismodegib.
 
Anne S. Tsao
Consulting or Advisory Role - Astellas Pharma; Boehringer Ingelheim; Genentech/Roche; Imedex; Lilly; MedImmune; Novartis
Research Funding - Genentech/Roche (Inst); MedImmune (Inst); Merck (Inst); Millennium; Seagen
Travel, Accommodations, Expenses - Novartis
 
Ignacio Ivan Wistuba
Consulting or Advisory Role - Ariad; AstraZeneca; Asuragen; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; GE Healthcare; Genecentric; Genentech/Roche; GlaxoSmithKline; HTG Molecular Diagnostics; Lilly; Lilly; Pfizer; Synta
Speakers' Bureau - Boehringer Ingelheim; Medscape; Pfizer
Research Funding - Bayer; Genentech; HTG Molecular Diagnostics; Jounce Therapeutics; Merck; Myriad Genetics; OncoPlex Diagnostics
 
Dianren Xia
No Relationships to Disclose
 
Lauren Averett Byers
Consulting or Advisory Role - Abbvie; AstraZeneca; Biomarin; Medivation
Research Funding - Takeda
 
Lixia Diao
No Relationships to Disclose
 
Jing Wang
No Relationships to Disclose
 
Vassiliki Papadimitrakopoulou
Consulting or Advisory Role - ARIAD; AstraZeneca; Biothera; Clovis Oncology; Genentech; Genentech; Gensignia Life Sciences; Janssen; Lilly; Merck
Research Funding - ACEA Biosciences (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
XiMing Tang
No Relationships to Disclose
 
Wei Lu
No Relationships to Disclose
 
Humam Kadara
No Relationships to Disclose
 
Zeynep H. Gumus
No Relationships to Disclose
 
Zhi Tan
No Relationships to Disclose
 
Shuxing Zhang
No Relationships to Disclose
 
Monique B. Nilsson
No Relationships to Disclose
 
John Heymach
Stock and Other Ownership Interests - Bio-Tree; Cardinal Spine
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; AstraZeneca; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Calithera Biosciences; Genentech; Medivation; Novartis; Oncomed; Synta
Research Funding - AstraZeneca (Inst)